In reply to vawedo and 2.1 Billion Dollars...
Ray said, direct quote: "Parenthetically, it has hardly escaped our notice that during the past quarter, Bristol Myers has paid $2.1 billion dollars for the HALF, that would be HALF, of the melanoma drug from Medarax that they did not already own, a drug known as Ipilimumab, also a compound that is pre-data."
Genasense is going to have data. And we have a better drug.
@smitter I only have one post left..any way to lift this from me?? i appreciate you sticky-ing that post earlier but if you are going to sticky one of them, sticky my conference call transcription :)
